12:00 AM
 | 
Apr 03, 2000
 |  BC Week In Review  |  Company News  |  Other News

Consensus Pharmaceuticals Inc. other research news

Consensus received a $99,000 Phase I SBIR grant from the National Institute of Allergy...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >